A new trading day began on Friday, with Wave Life Sciences Ltd (NASDAQ: WVE) stock price up 0.69% from the previous day of trading, before settling in for the closing price of $6.54. WVE’s price has ranged from $4.25 to $16.74 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 607.85% over the past five years. Meanwhile, its annual earnings per share averaged -41.23%. With a float of $123.05 million, this company’s outstanding shares have now reached $154.09 million.
Let’s look at the performance matrix of the company that is accounted for 288 employees. In terms of profitability, gross margin is 58.7%, operating margin of -101.94%, and the pretax margin is -89.57%.
Wave Life Sciences Ltd (WVE) Insider Updates
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Wave Life Sciences Ltd is 20.16%, while institutional ownership is 79.43%. The most recent insider transaction that took place on Mar 20 ’25, was worth 102,574. In this transaction Director of this company sold 10,500 shares at a rate of $9.77, taking the stock ownership to the 16,115 shares. Before that another transaction happened on Mar 20 ’25, when Company’s Director proposed sale 10,500 for $9.77, making the entire transaction worth $102,579.
Wave Life Sciences Ltd (WVE) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -41.23% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.36% during the next five years compared to 34.27% growth over the previous five years of trading.
Wave Life Sciences Ltd (NASDAQ: WVE) Trading Performance Indicators
Here are Wave Life Sciences Ltd’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.95. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -1.03 in one year’s time.
Technical Analysis of Wave Life Sciences Ltd (WVE)
Wave Life Sciences Ltd (NASDAQ: WVE) saw its 5-day average volume 2.25 million, a positive change from its year-to-date volume of 1.29 million. As of the previous 9 days, the stock’s Stochastic %D was 25.71%. Additionally, its Average True Range was 0.67.
During the past 100 days, Wave Life Sciences Ltd’s (WVE) raw stochastic average was set at 14.05%, which indicates a significant decrease from 34.84% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 97.02% in the past 14 days, which was higher than the 79.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $8.06, while its 200-day Moving Average is $9.94. Nevertheless, the first resistance level for the watch stands at $6.73 in the near term. At $6.87, the stock is likely to face the second major resistance level. The third major resistance level sits at $7.03. If the price goes on to break the first support level at $6.42, it is likely to go to the next support level at $6.26. Assuming the price breaks the second support level, the third support level stands at $6.12.
Wave Life Sciences Ltd (NASDAQ: WVE) Key Stats
With a market capitalization of 1.01 billion, the company has a total of 154,090K Shares Outstanding. Currently, annual sales are 108,300 K while annual income is -97,010 K. The company’s previous quarter sales were 83,750 K while its latest quarter income was 29,250 K.
